pharmanaming.com

professional naming for the healthcare & pharma industry

by Globrands/Labbrand Group

Search

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

by Jasmine Pennic / hitconsultant.net

2 min

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

61% of patients reported that they were likely to ask for a specific prescription medication by name, implying research prior to appointments, with Millennials the most likely generational group to ask for a specific prescription medication by name (69%). Consumers are increasingly leveraging online resources to both prepare for appointments and validate physician recommendations – moving beyond diagnosis to become more active in the treatment decision, according to new findi

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

© 2015 Amgen Inc. All Rights Reserved.

2 min

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

Tracking and tracing the use of all biologics, including biosimilars, enhances patient safety. Where there are multiple companies developing a biosimilar of the same reference molecule, distinct non-proprietary names for each of those biosimilars is fundamental to traceability. Physicians need complete and accurate data on adverse events linked to a specific treatment to facilitate optimal prescribing for each of their specific patients every time. An infrastructure that supp

Name that drug

Edward Carstairs of Gill Jennings & Every LLP

4 min

Name that drug

The role of the European Medicines Agency (EMA) as a regulator is to protect and promote public and animal health by evaluating and supervising medication for both human and veterinary use. The EMA was created to harmonise the working practices of the various EU member state territories. It also reduces the costs for those requiring approval throughout the EU. It is only after authorisation has been granted that a company can market a product. However, while regulatory approv

What's the Prescription for a Perfect Name?

By Paul Norman / Pharmaceutical Executive Europe

7 min

What's the Prescription for a Perfect Name?

With Viagra and Prozac rivaling McDonald's and Coca-Cola among today's most frequently used brand names, it's no surprise that pharmaceutical manufacturers are taking the whole issue of product branding very seriously. Gone are the days when consumers were happy to trust their pharmacist's advice when it came to cough mixture or heartburn remedy. Now, they frequently know exactly what they want and are even sufficiently well informed to ask their GPs to prescribe certain bran

EGA Becomes Medicines for Europe

By Pharmaceutical Executive Editors

3 min

EGA Becomes Medicines for Europe

The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued today, Medicines for Europe President Jacek Glinka explained that the repositioning "reflects our industries’ purpose and strategic objectives ... [W]e have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-mak

Hanmi's $200M China plant likely to make branded drugs versus generics

by Joseph Keenan / FiercePharma

2 min

Hanmi's $200M China plant likely to make branded drugs versus generics

South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently, be producing generic drugs at the facility. The company announced earlier this year it would build the plant on a 200,000-square-meter swath of land near Yantai in an economic development zone in the eastern province of Shandong. The facility will be the production site for chemosynthetic and biological drugs as well as various health foods

Top three therapy areas dominate pipelines

George Underwood / PharmaTimes

2 min

Top three therapy areas dominate pipelines

The world's top three therapy areas accounted for 68 percent of the overall pharmaceutical industry pipeline as of Q1 2016, according to business intelligence provider GBI Research. The company's Innovation Tracking Factbook 2016 states that oncology is by far the largest therapy area, with almost 7,000 products in active development, almost matching the combined size of the next two therapy areas, infectious diseases and central nervous system disorders, which each have over

GSK teams up with Google on bioelectronic medicines

by Selina McKee / PharmaTimes online

2 min

GSK teams up with Google on bioelectronic medicines

GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic medicines. The UK drugs giant is setting up a joint venture - Galvani Bioelectronics - with Alphabet division Verily Life Sciences to enable research, development and commercialisation of new products in this relatively new field, which involves the use of miniaturised, implantable devices to modify electrical signals that might help tackle chronic d

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

by Beth Snyder Bulik / FiercePharma

2 min

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the shift to outcomes-based healthcare is a sea change that will affect big pharma significantly. Still, exactly what does value-based care mean for pharma companies? What strategic and organizational changes will drug marketers need to make? Intouch Solutions believes the change will require major shifts in pharma drug strategy, execution and m

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

by Ari Altstedter and Manish Modi / Bloomberg

3 min

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace. The U.S. Food and Drug Administration has become something of a bogeyman for India’s stock market. An inspection blitz on Indian drug factories that supply to the U.S. helped push the broader index of Indian health-care stocks down by as much as 20 percent earlier this year from its all-time high in 2015 after some top firms received warnin

Featured Posts

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency

The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring...

How does the FDA 'approve' medical products?

How does the FDA 'approve' medical products?

You may have seen medical products that claim to be "FDA cleared," "FDA registered," "FDA listed" or "FDA approved" - but what do these...

The Secret Formula Behind Every Drug Name

The Secret Formula Behind Every Drug Name

Most people have no problem with famous names like Enbrel®, Prozac®, and Viagra®. But when it comes to understanding new drug names, such...

Branding and design in the medical/pharma industry

Branding and design in the medical/pharma industry

Communication is often seen as a touchy subject when it comes to the healthcare sector, given the tight regulations and fierce...

Pharma Brand Strategy 2.0

Learn about the building blocks of a great brand strategy that will have the potential to capture the full commercial value from a...

What Is an Active Pharmaceutical Ingredient (API)?

What Is an Active Pharmaceutical Ingredient (API)?

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination...

The Drug Naming Process

The Drug Naming Process

Drugs often have several names. A marketed drug may have up to four different types of names: a chemical name, a company name, a generic...

The twists and turns of naming diseases

The twists and turns of naming diseases

When a new disease is identified in a group of patients it needs a name so it can be described, researched and treated. But, unlike...

Branding: When One is Not Enough

Branding: When One is Not Enough

Launching a second brand is a marketing strategy to address an unmet need distinct from the current brand. In the pharmaceutical industry...

Liposomal medicine names to be changed to avoid errors

Liposomal medicine names to be changed to avoid errors

The EMA has requested that liposomal medication names be changed to avoid the risk of confusion. All marketing authorisation holders of...

The difference between pharmaceutical and biotechnology

The difference between pharmaceutical and biotechnology

While sitting in a meeting recently I was asked, 'what exactly is the difference between pharma and biopharma?' For most of us, we may...

Biosimilar names may affect pharmacist dispensing habits

Biosimilar names may affect pharmacist dispensing habits

How biosimilars are named could influence the willingness of pharmacists to substitute such drugs for more expensive biologics, a survey...

Branders give products an identity

Branders give products an identity

In the world of branding, there's a language all its own: Casodex, Grazax, Latisse, Symbicort and Vusion. Each one of those words is the...

The top 10 drugs of 2024

The top 10 drugs of 2024

EvaluatePharma analysts predict AbbVie's Humira will top pharma's sales charts in 2024, followed by Merck's Keytruda and Celgene's...

FDA Draft Guidance Requiring Distinct Naming for Biosimilars

FDA Draft Guidance Requiring Distinct Naming for Biosimilars

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency ATLANTA – The American College of Rheumatology (ACR) today...

A drug by any other name would work just as well — making sense of drug names

A drug by any other name would work just as well — making sense of drug names

How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare's play Romeo and Juliet,...

FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested

FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested

The U.S. Food and Drug Administration (Silver Spring, MD) has approved a pill that includes a sensor that digitally tracks if patients...

Can you teach old drugs new tricks?

Can you teach old drugs new tricks?

Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that...

'Accelerated approval' drugs: How well are they studied?

'Accelerated approval' drugs: How well are they studied?

When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and...

The FDA just approved the first direct competitor to a billion-dollar cancer drug

The FDA just approved the first direct competitor to a billion-dollar cancer drug

As it stands right now, biosimilars can't be used interchangeably with branded versions, meaning if you were to get a prescription for a...

Role of brand is 57% more likely to influence a recommendation compared to two years ago

A new report conducted by health branding agency InterbrandHealth measures the value that brands alone provide pharmaceutical companies....

What’s in a name? Billions of dollars in tech costs for biosimilars

What’s in a name? Billions of dollars in tech costs for biosimilars

A new US FDA guidance on how biological products licensed under the Public Health Service Act (PHS Act) need to be named is playing havoc...

How drug development is speeding up in the cloud

How drug development is speeding up in the cloud

Developing a drug from a promising molecule to a potential life-saver can take more than a decade and cost billions of dollars. Speeding...

Globalization in the pharmaceutical industry

Globalization in the pharmaceutical industry

Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch's publications...

Why Biosimilar Drug Names Contain Unhelpful Gibberish

Why Biosimilar Drug Names Contain Unhelpful Gibberish

Have you ever wondered how drugs are named? Is there ever a discernible meaning behind drug names? Who manages this mess anyway–drug...

Behind potent drug names, a complex mix of ingredients

Behind potent drug names, a complex mix of ingredients

Firms must navigate legal and linguistic hurdles for approval They are the public face of products that can take many years and hundreds...

Introducing The New Association For Accessible Medicines (AAM)

Introducing The New Association For Accessible Medicines (AAM)

The Generic Pharmaceutical Association (GPhA), the US largest trade group representing generic pharmaceutical and biosimilar companies,...

FDA Reiterates Decision on Suffixes in Biosimilar Naming

FDA Reiterates Decision on Suffixes in Biosimilar Naming

A Federal Register notice from FDA addressed comments on the guidance on Proprietary Naming of Biological Products and the agency’s...

Behind potent drug names, a complex mix of ingredients

Behind potent drug names, a complex mix of ingredients

Drug names start out as alien words: random collections of syllables that can sometimes seem almost as mind-boggling as the complicated...

New diagnostic name for stigmatizing term obesity

New diagnostic name for stigmatizing term obesity

The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) proposed Adiposity-Based Chronic...

The creative science of coining drug names

The creative science of coining drug names

With more than 30,000 proprietary drugs in the United States alone, coming up with a unique brand name is no easy task. Cialis, Eliquis,...

UK medicines regulation: responding to current challenges

UK medicines regulation: responding to current challenges

The medicines regulatory environment is evolving rapidly in response to the changing environment. Advances in science and technology have...

Probiotics in Favor of Life

Probiotics in Favor of Life

We all use the term “probiotic" so often, but may not think of what it means. The Russian Nobel Laureate Elie Metchnikoff, best known for...

Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry

Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry

The rise of global consumerism has shifted the healthcare landscape tremendously. People expect sophisticated levels of transparency and...

'Creation engineering': The art and science of naming drugs

'Creation engineering': The art and science of naming drugs

CNN)Yearly lists of the "most popular baby names" show how tastes change over time. While Jennifer, Heather, Michael and Jason may have...

Neuropathy: A name for their pain

Neuropathy: A name for their pain

People with neuropathic pain have struggled to find relief with conventional drugs. Researchers are investigating whether more meaningful...

FDA approves first automated insulin delivery device for type 1 diabetes

FDA approves first automated insulin delivery device for type 1 diabetes

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device...

How drug startups choose their brand

The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech...

Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Joint venture will research diabetes treatments Joshua Riff, who was a senior executive at UnitedHealth Group’s Optum, will be CEO of the...

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits

61% of patients reported that they were likely to ask for a specific prescription medication by name, implying research prior to...

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi

Tracking and tracing the use of all biologics, including biosimilars, enhances patient safety. Where there are multiple companies...

Name that drug

Name that drug

The role of the European Medicines Agency (EMA) as a regulator is to protect and promote public and animal health by evaluating and...

What's the Prescription for a Perfect Name?

What's the Prescription for a Perfect Name?

With Viagra and Prozac rivaling McDonald's and Coca-Cola among today's most frequently used brand names, it's no surprise that...

EGA Becomes Medicines for Europe

EGA Becomes Medicines for Europe

The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued...

Hanmi's $200M China plant likely to make branded drugs versus generics

Hanmi's $200M China plant likely to make branded drugs versus generics

South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently,...

Top three therapy areas dominate pipelines

Top three therapy areas dominate pipelines

The world's top three therapy areas accounted for 68 percent of the overall pharmaceutical industry pipeline as of Q1 2016, according to...

GSK teams up with Google on bioelectronic medicines

GSK teams up with Google on bioelectronic medicines

GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic...

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

Value-based care necessitates big changes for pharma marketers, says digital pharma agency

Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the...

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

India’s Drug Approvals Near Record Despite FDA Inspection Blitz

Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace....

With a Name Like Xalkori

With a Name Like Xalkori

New drug names aren’t just bizarre—they’re dangerous. What would Don Draper make of Xalkori? Pfizer’s lung cancer drug, released in 2011,...

Recent Posts

The Secret Formula Behind Every Drug Name

The Drug Naming Process

Archive

Search By Tags